RG 7834
Alternative Names: RO-7020322Latest Information Update: 09 Jun 2017
At a glance
- Originator Roche
- Class Antivirals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Hepatitis B
Most Recent Events
- 23 May 2017 Roche terminates a phase I trial in Hepatitis B in New Zealand, Hong Kong and Taiwan as the molecule development has been terminated(PO) (NCT02604355)
- 27 Apr 2017 Discontinued - Phase-I for Hepatitis B in Hong Kong, Taiwan (PO) (Roche pipeline, April 2017)
- 27 Apr 2017 Discontinued - Phase-I for Hepatitis B in New Zealand (PO) (Roche pipeline, April 2017)